Paul A. VanderLaan

6.8k total citations · 2 hit papers
150 papers, 4.1k citations indexed

About

Paul A. VanderLaan is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Paul A. VanderLaan has authored 150 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Pulmonary and Respiratory Medicine, 42 papers in Surgery and 38 papers in Oncology. Recurrent topics in Paul A. VanderLaan's work include Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Diagnosis and Treatment (38 papers) and Cancer Genomics and Diagnostics (19 papers). Paul A. VanderLaan is often cited by papers focused on Lung Cancer Treatments and Mutations (59 papers), Lung Cancer Diagnosis and Treatment (38 papers) and Cancer Genomics and Diagnostics (19 papers). Paul A. VanderLaan collaborates with scholars based in United States, Austria and Japan. Paul A. VanderLaan's co-authors include Catherine A. Reardon, Godfrey S. Getz, Daniel B. Costa, Jeffrey F. Krane, Deepa Rangachari, Mark S. Huberman, Ellen Marqusee, Erik Folch, Susumu Kobayashi and Adnan Majid and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Paul A. VanderLaan

135 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Brain metastases in patients with EGFR -mutated or ALK -rearranged non-small-cell lung cancers

2015 348 citations Deepa Rangachari, Paul A. VanderLaan et al. Lung Cancer profile →
The 2023 Bethesda System for Reporting Thyroid Cytopathology

2023 147 citations Fernando Schmitt, Paul A. VanderLaan et al. profile →

Peers

Countries citing papers authored by Paul A. VanderLaan

Since Specialization

Citations

This map shows the geographic impact of Paul A. VanderLaan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. VanderLaan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. VanderLaan more than expected).

Fields of papers citing papers by Paul A. VanderLaan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. VanderLaan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. VanderLaan. The network helps show where Paul A. VanderLaan may publish in the future.

Co-authorship network of co-authors of Paul A. VanderLaan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. VanderLaan. A scholar is included among the top collaborators of Paul A. VanderLaan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. VanderLaan. Paul A. VanderLaan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Endobronchial ultrasound-guided sampling: diagnostic yield of needle biopsy and cryobiopsy in addition to needle aspiration 2025 ·Annals of the American Thoracic Society ·Jason Beattie, (unknown), Jacqueline Chen, Aleem Bharwani, Juan Sebastián Lara, (unknown), (unknown), Mihir Parikh, (unknown), Paul A. VanderLaan, Adnan Majid	0
2	Bronchoscopic Microwave Ablation of Peripheral Lung Cancer: Initial Experience of a Treat and Resect Study 2025 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Jennifer L. Wilson, Cristiana M. Pineda, (unknown), Aleem Bharwani, Paul A. VanderLaan, Ritu R. Gill, Richard I. Whyte, Michal Šenitko, (unknown), (unknown), George Z. Cheng, (unknown), Sidhu P. Gangadharan, Mihir Parikh, Adnan Majid, (unknown)	0
3	Optimizing cytology and small biopsy specimen processing for ancillary studies: recommendations from the American Society of Cytopathology taskforce 2025 ·Journal of the American Society of Cytopathology ·Sinchita Roy‐Chowdhuri, Christine N. Booth, Jonas J. Heymann, (unknown), Joshua Menke, Sara E. Monaco, Ritu Nayar, Michiya Nishino, Roberto Ruiz‐Cordero, (unknown), Anjali Saqi, Kaitlin E. Sundling, Michael J. Thrall, Vanda F. Torous, Christopher J. VandenBussche, M. Lisa Zhang, Momin T. Siddiqui, Paul A. VanderLaan	0
4	Kratom Toxicity: A Mimicker of Fulminant Myocarditis 2025 ·The Journal of Heart and Lung Transplantation ·(unknown), (unknown), Apparao M. Rao, Ashok Kumar Pannu, (unknown), Pablo Quintero, A.R. Garan, E. Wilson Grandin, Paul A. VanderLaan, Roger J. Laham, Marwa Sabe	0
5	Pericardial effusion cytology: malignancy rates, patterns of metastasis, comparison with pericardial window, and genomic correlates 2024 ·Journal of the American Society of Cytopathology ·Vanda F. Torous, Cristiana M. Pineda, (unknown), Ivan Chebib, Paul A. VanderLaan	0
6	Tools, techniques, and challenges in preparing cytology specimens for ancillary studies: results of the ASC Optimizing Cytology and Small Biopsy Specimen Processing for Ancillary Studies task force survey 2024 ·Journal of the American Society of Cytopathology ·Jonas J. Heymann, Cristiana M. Pineda, (unknown), (unknown), Joshua Menke, Sara E. Monaco, Ritu Nayar, Michiya Nishino, Sinchita Roy‐Chowdhuri, Roberto Ruiz‐Cordero, (unknown), Anjali Saqi, Kaitlin E. Sundling, Michael J. Thrall, Vanda F. Torous, Christopher J. VandenBussche, Paul A. VanderLaan, (unknown), Momin T. Siddiqui	1
7	A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice 2024 ·Cancers ·Hollis Viray, Andrew J. Piper‐Vallillo, Page Widick, Emmeline C. Academia, Meghan Shea, Deepa Rangachari, Paul A. VanderLaan, Susumu Kobayashi, Daniel B. Costa	4
8	Gastrointestinal stromal tumors in fine‐needle aspiration biopsies 2024 ·Diagnostic Cytopathology ·(unknown), (unknown), Paul A. VanderLaan, (unknown)	0
9	Multi-institutional 10-year retrospective review of amoeba diagnosed on cytologic evaluation of anal pap tests: what is the significance? 2023 ·Journal of the American Society of Cytopathology ·(unknown), (unknown), Paul A. VanderLaan, Vanda F. Torous	1
10	The Impact of On-Target Resistance Mediated by EGFR-T790M or EGFR-C797S on EGFR Exon 20 Insertion Mutation Active Tyrosine Kinase Inhibitors 2023 ·JTO Clinical and Research Reports ·Ikei S. Kobayashi, (unknown), Hollis Viray, Deepa Rangachari, Paul A. VanderLaan, Susumu Kobayashi, Daniel B. Costa	6
11	EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors 2023 ·Lung Cancer ·(unknown), Ikei S. Kobayashi, (unknown), Shriram K. Sundararaman, Meghan Lee, Deepa Rangachari, Paul A. VanderLaan, Susumu Kobayashi, Daniel B. Costa	3
12	A brief review of the WHO reporting system for lung cytopathology 2023 ·Journal of the American Society of Cytopathology ·Şule Canberk, Andrew Field, Lukas Bubendorf, Ashish Chandra, Ian A. Cree, (unknown), Kenzo Hiroshima, Deepali Jain, Ivana Kholová, Lester J. Layfield, Ravi Mehrotra, (unknown), R. Yoshiyuki Osamura, Martha B. Pitman, Sinchita Roy‐Chowdhuri, Yukitoshi Satoh, Paul A. VanderLaan, Maureen F. Zakowski, Fernando Schmitt	12
13	Massive Thymic Hyperplasia Masquerading as Cancer: A Case Report and Review of the Literature 2023 ·JTO Clinical and Research Reports ·(unknown), (unknown), (unknown), Zsu‐Zsu Chen, Paul A. VanderLaan, Deepa Rangachari	1
14	Percutaneous Aspiration of Lead-Associated Vegetation During Pacemaker Extraction in a Patient With Polymicrobial Device Infection 2023 ·JACC. Clinical electrophysiology ·Timothy Maher, Robert DʼAngelo, (unknown), (unknown), Paul A. VanderLaan, (unknown), Isaac E. Stillman, Peter Zimetbaum	1
15	EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates 2023 ·Translational Lung Cancer Research ·(unknown), Emmeline C. Academia, Hollis Viray, Deepa Rangachari, Susumu Kobayashi, Paul A. VanderLaan, Daniel B. Costa	16
16	The Growth Rate of Subsolid Lung Adenocarcinoma Nodules at Chest CT 2020 ·Radiology ·Constance de Margerie‐Mellon, Long Ngo, Ritu R. Gill, (unknown), Benedikt H. Heidinger, (unknown), (unknown), Paul A. VanderLaan, Alexander A. Bankier	19
17	Results from the 2019 American Society of Cytopathology survey on rapid onsite evaluation (ROSE)–part 2: subjective views among the cytopathology community 2020 ·Journal of the American Society of Cytopathology ·Jennifer L. Sauter, (unknown), Deepu Alex, Ronald Balassanian, (unknown), Melina Flanagan, Christopher C. Griffith, Peter B. Illei, Daniel N. Johnson, Cindy McGrath, Melissa Randolph, Jordan Reynolds, (unknown), Annemieke van Zante, Paul A. VanderLaan	10
18	The rapidly evolving landscape of biomarker testing in non–small cell lung cancer 2020 ·Cancer Cytopathology ·Paul A. VanderLaan, Deepa Rangachari, Daniel B. Costa	19
19	Results from the 2019 American Society of Cytopathology survey on rapid on-site evaluation—Part 1: objective practice patterns 2019 ·Journal of the American Society of Cytopathology ·Paul A. VanderLaan, (unknown), Deepu Alex, Ronald Balassanian, (unknown), Rana S. Hoda, Peter B. Illei, Cindy McGrath, Melissa Randolph, Jordan Reynolds, (unknown), (unknown), Annemieke van Zante, Jennifer L. Sauter	34
20	P1.02-031 Mutations in TP53, PIK3CA, PTEN and Other Genes in EGFR Mutated Lung Cancers: Correlation with Clinical Outcomes 2017 ·Journal of Thoracic Oncology ·Paul A. VanderLaan, Deepa Rangachari, Susan M. Mockus, (unknown), Honey V. Reddi, (unknown), Mark S. Huberman, Loren Joseph, Susumu Kobayashi, Daniel B. Costa	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact